3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
5
Glioblastoma
4
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Glioma
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pleural Neoplasms
1
Pancreatic Cyst
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Mesothelioma
1
Medication Adherence
1
Margins of Excision
1
Lymphedema
1
Lung Diseases
1
Liver Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Early-stage Peripheral Non-small Cell Lung Cancer
1
Interventions
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Blood Specimen Collection
6
Prednisone
5
Positron Emission Tomography Computed Tomography
4
Mammography
4
Lenalidomide
4
Colonoscopy
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surveys and Questionnaires
3
Melphalan
3
Exercise
3
Biopsy
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Methods
2
Magnetic Resonance Imaging
2
Injections
2
Gemcitabine
2
Educational Status
2
Doxorubicin
2
Cytarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Disease
×
Drug Delivery Systems
×
Clear all
NCT01373671
2020-08-07
DBT
Siemens Medical Solutions USA - CSG
Phase NA
Completed
764 enrolled
5 charts